Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,509 | 138 | 95.3% |
| Education | $124.61 | 2 | 4.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $275.79 | 16 | $0 (2023) |
| PFIZER INC. | $224.46 | 11 | $0 (2023) |
| Amgen Inc. | $221.17 | 13 | $0 (2023) |
| Novo Nordisk Inc | $216.72 | 12 | $0 (2023) |
| Amarin Pharma Inc. | $197.96 | 11 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $160.78 | 8 | $0 (2023) |
| Genentech USA, Inc. | $157.47 | 4 | $0 (2018) |
| Bayer Healthcare Pharmaceuticals Inc. | $150.10 | 7 | $0 (2023) |
| Relypsa, Inc. | $122.32 | 7 | $0 (2019) |
| GlaxoSmithKline, LLC. | $120.80 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $42.18 | 2 | AKEBIA THERAPEUTICS INC ($24.61) |
| 2023 | $649.27 | 33 | Lilly USA, LLC ($124.62) |
| 2022 | $296.94 | 17 | Bayer HealthCare Pharmaceuticals Inc. ($57.42) |
| 2021 | $524.30 | 29 | Amarin Pharma Inc. ($91.26) |
| 2020 | $273.53 | 15 | Amarin Pharma Inc. ($82.83) |
| 2019 | $184.75 | 10 | Daiichi Sankyo Inc. ($38.18) |
| 2018 | $222.57 | 8 | Genentech USA, Inc. ($100.00) |
| 2017 | $440.13 | 26 | Relypsa, Inc. ($86.65) |
All Payment Transactions
140 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Education | In-kind items and services | $24.61 | General |
| Category: Nephrology | ||||||
| 01/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: RESPIRATORY | ||||||
| 12/13/2023 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Diabetes | ||||||
| 10/31/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Cardiology | ||||||
| 10/30/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: Diabetes Care | ||||||
| 10/30/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: RESPIRATORY | ||||||
| 10/25/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.01 | General |
| Category: DIABETES | ||||||
| 10/18/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Diabetes | ||||||
| 10/02/2023 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: Diabetes | ||||||
| 09/13/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Diabetes | ||||||
| 09/13/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: RESPIRATORY | ||||||
| 09/05/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Oncology | ||||||
| 08/28/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Diabetes | ||||||
| 08/10/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Diabetes | ||||||
| 07/17/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Oncology | ||||||
| 07/10/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Diabetes | ||||||
| 07/06/2023 | Alnylam Pharmaceuticals Inc. | OXLUMO (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: Genetic Disease | ||||||
| 06/27/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.53 | General |
| 06/22/2023 | LINUS HEALTH, INC. | CORE COGNITIVE EVALUATION (Device) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: DEVICE | ||||||
| 06/13/2023 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: NEPHROLOGY | ||||||
| 06/13/2023 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $18.13 | General |
| Category: Ophthalmology | ||||||
| 05/23/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/11/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/09/2023 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $30.64 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 946 | 1,697 | $363,811 | $183,696 |
| 2022 | 15 | 872 | 1,528 | $281,687 | $179,137 |
| 2021 | 18 | 997 | 1,811 | $431,720 | $218,977 |
| 2020 | 15 | 1,074 | 1,952 | $377,172 | $193,696 |
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 248 | 613 | $153,227 | $79,210 | 51.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 208 | 392 | $88,200 | $39,331 | 44.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 144 | 144 | $32,528 | $18,693 | 57.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 34 | 144 | $28,800 | $14,024 | 48.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 37 | 54 | $18,900 | $11,888 | 62.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 40 | 63 | $18,900 | $8,938 | 47.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 20 | 43 | $7,525 | $2,784 | 37.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 31 | 31 | $2,635 | $2,350 | 89.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 21 | 46 | $3,220 | $1,765 | 54.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 89 | 89 | $3,115 | $1,648 | 52.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 12 | 16 | $2,400 | $1,054 | 43.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 31 | 31 | $1,550 | $978.36 | 63.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 11 | $2,175 | $806.63 | 37.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 20 | 20 | $635.00 | $225.34 | 35.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 302 | 777 | $176,694 | $108,916 | 61.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 131 | 131 | $21,361 | $17,511 | 82.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 30 | 138 | $21,061 | $11,584 | 55.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 59 | 59 | $12,369 | $10,173 | 82.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 31 | 44 | $15,258 | $10,045 | 65.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 27 | 52 | $14,632 | $8,418 | 57.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 55 | 68 | $11,010 | $6,847 | 62.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 22 | 22 | $1,870 | $1,546 | 82.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 82 | 82 | $1,870 | $1,527 | 81.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 12 | 17 | $1,865 | $1,003 | 53.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 22 | 22 | $1,376 | $662.42 | 48.1% |
About Dr. Kenneth Rappaport, D.O
Dr. Kenneth Rappaport, D.O is a Internal Medicine healthcare provider based in Palm Beach Gardens, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1447210372.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenneth Rappaport, D.O has received a total of $2,634 in payments from pharmaceutical and medical device companies, with $42.18 received in 2024. These payments were reported across 140 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($2,509).
As a Medicare-enrolled provider, Rappaport has provided services to 3,889 Medicare beneficiaries, totaling 6,988 services with total Medicare billing of $775,505. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Nephrology
- Location Palm Beach Gardens, FL
- Active Since 03/24/2006
- Last Updated 09/24/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1447210372
Products in Payments
- Vascepa (Drug) $197.96
- ELIQUIS (Drug) $159.79
- Rituxan (Biological) $157.47
- Kerendia (Drug) $150.10
- MOUNJARO (Drug) $132.00
- Veltassa (Drug) $122.32
- TRELEGY ELLIPTA (Drug) $120.80
- Ozempic (Drug) $111.99
- JYNARQUE (Drug) $105.92
- TRULICITY (Drug) $103.69
- Cologuard Collection Kit (Device) $95.51
- CHANTIX (Drug) $70.36
- Livalo (Drug) $63.76
- ACTHAR (Biological) $59.24
- SAMSCA (Drug) $54.86
- Parsabiv (Biological) $53.38
- Parsabiv (Drug) $51.41
- JARDIANCE (Drug) $49.44
- UBRELVY (Drug) $40.46
- FARXIGA (Drug) $39.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Palm Beach Gardens
Dr. Ravi Pandey, Md, MD
Internal Medicine — Payments: $17,395
Dr. Rupesh Dharia, M.d, M.D
Internal Medicine — Payments: $15,087
Amir Fahmy, Md, MD
Internal Medicine — Payments: $12,315
Romel Arjona, M.d, M.D
Internal Medicine — Payments: $9,757
Alissa O'brien, M.d, M.D
Internal Medicine — Payments: $7,028
Javier Canasi, Md, MD
Internal Medicine — Payments: $4,890